LY-334370
LY-334370 is a pharmaceutical drug that was developed by Eli Lilly and Company, a multinational pharmaceutical company. It is a selective 5-HT1F receptor agonist, and was primarily researched for the treatment of migraine.
History[edit]
LY-334370 was first synthesized by researchers at Eli Lilly and Company. The drug was developed as a part of the company's ongoing research into the therapeutic potential of 5-HT1F receptor agonists. The development of LY-334370 was based on the hypothesis that selective activation of 5-HT1F receptors could provide relief from migraine without the cardiovascular side effects associated with other serotonin receptor agonists.
Pharmacology[edit]
LY-334370 is a selective agonist for the 5-HT1F receptor, a type of serotonin receptor. Serotonin receptors are a group of G protein-coupled receptors (GPCRs) and ligand-gated ion channels found in the central nervous system and peripheral nervous system. The 5-HT1F receptor subtype is primarily found in the brain, and is thought to play a role in the pathophysiology of migraine.
Clinical Trials[edit]
In clinical trials, LY-334370 was found to be effective in the treatment of acute migraine. However, the development of the drug was discontinued for reasons that were not publicly disclosed. Despite the discontinuation of LY-334370, the results of the clinical trials provided valuable evidence for the potential of 5-HT1F receptor agonists in the treatment of migraine.
Legacy[edit]
The research into LY-334370 has had a significant impact on the field of migraine research. The positive results from the clinical trials of LY-334370 led to further research into 5-HT1F receptor agonists. This research eventually led to the development of Lasmiditan, another 5-HT1F receptor agonist developed by Eli Lilly and Company, which was approved by the Food and Drug Administration (FDA) for the treatment of acute migraine in 2019.
See Also[edit]
LY-334370[edit]
-
LY334370.svg -
LY-334370 3D BS.png
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
